APA (7th ed.) Citation

M, C., G, M., N, M., F, D., G, T., G, G., . . . P, B. (2014). Off-label thrombolysis versus full adherence to the current European Alteplase license: Impact on early clinical outcomes after acute ischemic stroke. Journal of thrombosis and thrombolysis, 37(4), 549. https://doi.org/10.1007/s11239-013-0980-2

Chicago Style (17th ed.) Citation

M, Cappellari, et al. "Off-label Thrombolysis Versus Full Adherence to the Current European Alteplase License: Impact on Early Clinical Outcomes After Acute Ischemic Stroke." Journal of Thrombosis and Thrombolysis 37, no. 4 (2014): 549. https://doi.org/10.1007/s11239-013-0980-2.

MLA (9th ed.) Citation

M, Cappellari, et al. "Off-label Thrombolysis Versus Full Adherence to the Current European Alteplase License: Impact on Early Clinical Outcomes After Acute Ischemic Stroke." Journal of Thrombosis and Thrombolysis, vol. 37, no. 4, 2014, p. 549, https://doi.org/10.1007/s11239-013-0980-2.